1-3 of 3
Thorsten Ross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel Bispecific Innate Cell Engager (ICE®) AFM28 Efficiently Directs Allogeneic NK Cells to CD123+ Leukemic Stem- and Progenitor Cells in AML

Nanni Schmitt, Jana-Julia Siegler, Lena Wagner, Nicole Schulze, Alexandra Beck, Wolf-Karsten Hofmann, Torsten Haneke, Uwe Reusch, José Medina-Echeverz, Jan Endell, Thorsten Ross, Christian Merz, Daniel Nowak
Journal: Blood
Blood (2022) 140 (Supplement 1): 8815–8816.
https://doi.org/10.1182/blood-2022-169729
Published: 2022
Journal Articles

AFM28, a Novel Bispecific Innate Cell Engager (ICE ® ), Designed to Selectively Re-Direct NK Cell Lysis to CD123+ Leukemic Cells in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Jana-Julia Götz, Jens Pahl, Nanni Schmitt, Thomas Müller, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Stefan Knackmuss, Eike Peters, Uwe Reusch, Thorsten Ross, Daniel Nowak, Wolf-Karsten Hofmann, Christian Merz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2021-152463
Published: 2021
Journal Articles

Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma

Thorsten Ross, PhD, Uwe Reusch, PhD, Susanne Wingert, PhD, Torsten Haneke, PhD, Katja Klausz, PhD, Anna-Kathrin Otte, PhD, Natalie Schub, MD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Thomas Valerius, MD, Martin Gramatzki, MD, Matthias Peipp, PhD, Michael Tesar, PhD, Erich Rajkovic, PhD MBA, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1927.
https://doi.org/10.1182/blood-2018-99-118970
Published: 2018